Moves quickly to cap prices of two molecules Sitagliptin and Linagliptin and their combinations
from News https://ift.tt/3JmigKq
Friday, 26 August 2022
Pricing regulator closely watching prices of diabetes drug going off patent
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment